Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$4.5 - $7.51 $69,057 - $115,248
15,346 Added 1482.71%
16,381 $108,000
Q2 2023

Aug 14, 2023

BUY
$9.23 - $11.23 $9,553 - $11,623
1,035 New
1,035 $10,000
Q2 2021

Aug 11, 2021

SELL
$11.7 - $16.11 $55,680 - $76,667
-4,759 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$12.84 - $17.26 $15,446 - $20,763
-1,203 Reduced 20.18%
4,759 $70,000
Q4 2020

Feb 16, 2021

BUY
$14.61 - $17.59 $36,525 - $43,975
2,500 Added 72.21%
5,962 $90,000
Q3 2020

Nov 12, 2020

BUY
$11.64 - $16.86 $10,941 - $15,848
940 Added 37.27%
3,462 $57,000
Q2 2020

Aug 13, 2020

BUY
$7.75 - $22.61 $19,545 - $57,022
2,522 New
2,522 $32,000

Others Institutions Holding TELA

About TELA Bio, Inc.


  • Ticker TELA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 19,157,600
  • Market Cap $53.4M
  • Description
  • TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...
More about TELA
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.